HomeNewsTrendsHealthIIT Delhi researchers develop RT-PCR based assay for detection of Omicron variant within 90 minutes

IIT Delhi researchers develop RT-PCR based assay for detection of Omicron variant within 90 minutes

Currently, the identification or screening for Omicron is done worldwide using next-generation sequencing-based methods which require over three days.

December 13, 2021 / 22:18 IST
Story continues below Advertisement
Representative image: AP
Representative image: AP

Researchers at the Indian Institute of Technology (IIT), Delhi have developed an RT-PCR based assay for the specific detection of the Omicron variant of COVID-19 within 90 minutes, according to officials.

Currently, the identification or screening for Omicron is done worldwide using next-generation sequencing-based methods which require over three days.

Story continues below Advertisement

The institute has filed an Indian patent application for the rapid screening assay developed by its Kusuma School of Biological Sciences and is in process of initiating talks with potential industry partners.

"The assay is based on detecting specific mutations which are present in the Omicron variant and absent in other currently circulating variants of SARS-CoV-2. Primer sets targeting these unique mutations in the S gene were designed for the specific amplification of either the Omicron variant or other currently circulating variants of SARS-CoV-2 and tested using real time PCR," a senior IIT Delhi official said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show